HNCRX
Price
$24.57
Change
+$0.23 (+0.94%)
Updated
Jun 2 closing price
Net Assets
506.18M
RERAX
Price
$62.76
Change
+$0.33 (+0.53%)
Updated
Jun 2 closing price
Net Assets
136.57B
Interact to see
Advertisement

HNCRX vs RERAX

Header iconHNCRX vs RERAX Comparison
Open Charts HNCRX vs RERAXBanner chart's image
HNCRX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
HNCRX vs. RERAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNCRX is a Buy and RERAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 137B vs. HNCRX (506M). RERAX pays higher dividends than HNCRX: RERAX (2.19) vs HNCRX (0.35). HNCRX was incepted earlier than RERAX: HNCRX (19 years) vs RERAX (24 years). HNCRX (1.61) and RERAX (1.57) have similar cost to investors . HNCRX (36.00) and RERAX (35.00) have comparable annual turnover. HNCRX has a lower initial minimum investment than RERAX: HNCRX (0) vs RERAX (250). HNCRX annual gain was more profitable for investors over the last year : 24.92 vs. RERAX (13.13). HNCRX return over 5 years is better than : 23.10 vs. RERAX (-6.22).
HNCRXRERAXHNCRX / RERAX
Total Expense Ratio1.571.57100%
Annual Report Gross Expense Ratio1.611.57103%
Fund Existence19 years24 years-
Gain YTD12.73711.224113%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets506M137B0%
Annual Yield % from dividends0.352.1916%
Returns for 1 year24.9213.13190%
Returns for 3 years57.3127.83206%
Returns for 5 years23.10-6.22-371%
Returns for 10 years101.6050.27202%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK463.416.70
+1.47%
Rockwell Automation
IMSR9.600.11
+1.16%
Terrestrial Energy Inc.
SBRA18.58-0.48
-2.49%
Sabra Health Care REIT
ACB3.53-0.12
-3.16%
Aurora Cannabis
CTXR0.60-0.03
-4.84%
Citius Pharmaceuticals Inc